Christopher M. Bussineau
Operationeel Directeur bij BioVascular, Inc.
Profiel
Christopher M.
Bussineau is currently the Vice President-Pharmaceutical Operations at BioVascular, Inc. He previously worked as the Senior Director-Technical Operations at Chiron Corp.
and as the Vice President & General Manager at Cambrex Bio Science Baltimore, Inc. Bussineau holds a doctorate degree from Rice University and an undergraduate degree from the University of California San Diego.
Actieve functies van Christopher M. Bussineau
| Bedrijven | Functie | Begin |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Operationeel Directeur | - |
Eerdere bekende functies van Christopher M. Bussineau
| Bedrijven | Functie | Einde |
|---|---|---|
| Cambrex Bio Science Baltimore, Inc. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Christopher M. Bussineau
| Rice University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cambrex Bio Science Baltimore, Inc. |
